Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Susan L. Pendland"'
Autor:
Susan L. Pendland, Manjunath P. Pai
Publikováno v:
Annals of Pharmacotherapy. 37:192-196
BACKGROUND: An assessment of antifungal susceptibility testing (AST) has not been conducted since the introduction of the National Committee for Clinical Laboratory Standards (NCCLS) M27-A document. OBJECTIVE: To determine AST practices in teaching h
Publikováno v:
Phytotherapy Research. 17:217-221
Methanol extracts of the rhizomes of Sanguinaria canadensis, and the roots and rhizomes of Hydrastis canadensis, two plants used traditionally for the treatment of gastrointestinal ailments, were screened for in vitro antibacterial activity against 1
Publikováno v:
Chemotherapy. 49:1-7
Background: Perfluorooctyl bromide (PFOB) is administered directly into the lungs of critically ill patients during partial liquid ventilation. This adjunctive therapy facilitates respiratory support in lung-injured patients and potentially interacts
Publikováno v:
Journal of Antimicrobial Chemotherapy. 49:857-861
The intracellular activity of ABT-773 against Legionella pneumophila was compared with azithromycin and ciprofloxacin using HL-60 cells. Against L. pneumophila ATCC 33152 and three clinical isolates the MICs (mg/L) were ABT-773 0.015, ciprofloxacin 0
Publikováno v:
Pharmacotherapy. 22:14-20
Study Objective. To determine epidemiologic factors of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae in a nonoutbreak setting. Design. Retrospective analysis. Setting. University teaching hospital. Patients
Publikováno v:
Journal of Antimicrobial Chemotherapy. 44:831-834
This study used a modified time-kill assay to compare the in-vitro activity of chloramphenicol and quinopristin/dalfopristin combined with vancomycin, ampicillin or gentamicin against multidrug-resistant Enterococcus faecium. The assay uses standardi
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 32:95-99
This investigation used checkerboard and time-kill assays to evaluate the in vitro activity of RPR 106972 (45% pristinamycin IB and 55% pristinamycin IIB) alone and in combination with vancomycin or ampicillin +/- gentamicin against multidrug-resista
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 29:167-171
Clarithromycin is metabolized to an active metabolite, 14-hydroxy clarithromycin. These compounds have demonstrated excellent in vitro activity against Legionella species, with both agents having significantly lower MICs than erythromycin. Using a ch
Autor:
Larry H. Danziger, Lori L. Schoonover, Keith A. Rodvold, Eric B. Rypins, Donna J. Occhipinti, Susan L. Pendland
Publikováno v:
Antimicrobial Agents and Chemotherapy. 41:2511-2517
The pharmacokinetics and pharmacodynamics of two multiple-dose regimens of piperacillin-tazobactam (3.375 g every 6 h and 4.5 g every 8 h) were evaluated at steady state for 12 healthy adult volunteers. Inhibitory and bactericidal activities for the
Autor:
Susan L. Pendland, Larry H. Danziger
Publikováno v:
American Journal of Health-System Pharmacy. 52:S3-S8
The historical development of antibiotic resistance, mechanisms of resistance, classification schemes for beta-lactamases, the clinical relevance of resistance, and approaches to overcoming resistance are reviewed. The promise of eradication of infec